According to Iran’s Food and Drug Administration, during that sanctions period, the list of medicines subject to shortages in Iran extended to 350 drugs. After the lifting of international sanctions as part of the Iran nuclear deal, the situation improved dramatically.
With U.S. sanctions poised to return, much suffering for Iranians seems to be on the horizon. In fact, what the Trump administration is seeking to do could prove much more dangerous than anything Iran has been subjected to before.
[Bourse & Bazaar]